Computational Docking as a Tool in Guiding the Drug Design of Rutaecarpine Derivatives as Potential SARS-CoV-2 Inhibitors
Molecules · 2024
DOI: 10.3390/molecules29112636 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Shengying Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Chinese Medicine, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China. Hauptthemen laut MEDLINE: Indole Alkaloids, SARS-CoV-2, Molecular Docking Simulation, Quinazolines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health and Medical Research Fund, Hong Kong Government Food and Health Bureau, Zhongshan Municipal Bureau of Science and Technology.
Abstract (Originalsprache)
COVID-19 continues to spread around the world. This is mainly because new variants of the SARS-CoV-2 virus emerge due to genomic mutations, evade the immune system and result in the effectiveness of current therapeutics being reduced. We previously established a series of detection platforms, comprising computational docking analysis, S-protein-based ELISA, pseudovirus entry, and 3CL protease activity assays, which allow us to screen a large library of phytochemicals from natural products and to determine their potential in blocking the entry of SARS-CoV-2. In this new screen, rutaecarpine (an alkaloid from Evodia rutaecarpa) was identified as exhibiting anti-SARS-CoV-2 activity. Therefore, we conducted multiple rounds of structure-activity-relationship (SAR) studies around this phytochemical and generated several rutaecarpine analogs that were subjected to in vitro evaluations. Among these derivatives, RU-75 and RU-184 displayed remarkable inhibitory activity when tested in the 3CL protease assay, S-protein-based ELISA, and pseudovirus entry assay (for both wild-type and omicron variants), and they attenuated the inflammatory response induced by SARS-CoV-2. Interestingly, RU-75 and RU-184 both appeared to be more potent than rutaecarpine itself, and this suggests that they might be considered as lead candidates for future pharmacological elaboration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Chinese Medicine, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China.
- State Key Laboratory of Molecular Neuroscience, Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China.
ORCID-Profile: Shengying Lin, Xiaoyang Wang, Ka Wing Leung, Sarah E Webb
Förderung
- Health and Medical Research Fund
- Hong Kong Government Food and Health Bureau
- Zhongshan Municipal Bureau of Science and Technology
- Hong Kong Innovation Technology Fund (ITCPD/17-9)
- Shenzhen Science and Technology Innovation Committee
- Hong Kong RGC Theme-Based Research Scheme
- Key-Area Research and Development Program of Guangdong Province
- GBA Institute of Collaborate Innovation
Zitieren
APA
Lin, S., Wang, X., Tang, R. W., Duan, R., Leung, K. W., Dong, T. T., Webb, S. E., Miller, A. L., & Tsim, K. W. (2024). Computational Docking as a Tool in Guiding the Drug Design of Rutaecarpine Derivatives as Potential SARS-CoV-2 Inhibitors. Molecules. https://doi.org/10.3390/molecules29112636
Vancouver
Lin S, Wang X, Tang RW, Duan R, Leung KW, Dong TT, et al. Computational Docking as a Tool in Guiding the Drug Design of Rutaecarpine Derivatives as Potential SARS-CoV-2 Inhibitors. Molecules. 2024. doi:10.3390/molecules29112636
BibTeX
@article{Lin2024,
author = {Lin, Shengying and Wang, Xiaoyang and Tang, Roy Wai-Lun and Duan, Ran and Leung, Ka Wing and Dong, Tina Ting-Xia and Webb, Sarah E and Miller, Andrew L and Tsim, Karl Wah-Keung},
title = {Computational Docking as a Tool in Guiding the Drug Design of Rutaecarpine Derivatives as Potential SARS-CoV-2 Inhibitors},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29112636}
}
EUVIMED